243 related articles for article (PubMed ID: 6708030)
1. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
Lauersen NH; Graves ZR
J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
[TBL] [Abstract][Full Text] [Related]
2. [Cervical dilatation by use of a vaginal suppository of meteneprost before voluntary interruption of the pregnancy in the first trimester].
Maria B; André-David F; Oury JF; Stampf F; Bresson E; Rosenberg P
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):637-42. PubMed ID: 3668189
[TBL] [Abstract][Full Text] [Related]
3. [Use of a new vaginal suppository: prostaglandin E1 analog Gemeprost for cervix maturation prior to abortion in the 1st trimester].
Rabe T; Helk J; Kiesel L; Zwick J; Runnebaum B
Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):393-401. PubMed ID: 3894147
[TBL] [Abstract][Full Text] [Related]
4. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
5. Use of different prostaglandin analogues for terminating pregnancy at different terms.
Manuilova IA
Acta Med Hung; 1986; 43(2):133-8. PubMed ID: 3588156
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
Friedli A; De Grandi P
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
[TBL] [Abstract][Full Text] [Related]
7. A comparison of two stable prostaglandin E analogues for termination of early pregnancy and for cervical dilatation.
Bygdeman M; Bremme K; Christensen N; Lundström V; Gréen K
Contraception; 1980 Nov; 22(5):471-83. PubMed ID: 7471738
[TBL] [Abstract][Full Text] [Related]
8. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative cervix dilatation in 1st trimester pregnancy interruption using 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2. A randomized double-blind study].
Brügger D; Dreher E
Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):567-9. PubMed ID: 4043711
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
Sidhu MS; Kent DR
Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
[TBL] [Abstract][Full Text] [Related]
11. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
[TBL] [Abstract][Full Text] [Related]
12. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
13. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
Somell C; Olund A
Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
[TBL] [Abstract][Full Text] [Related]
14. Preoperative cervical dilatation with a single long-acting prostaglandin analog suppository. An alternative to traumatic mechanical dilatation before surgical evacuation.
Kent DR; Goldstein AI; Milokovich D
J Reprod Med; 1983 Nov; 28(11):778-80. PubMed ID: 6655636
[TBL] [Abstract][Full Text] [Related]
15. Menstrual regulation with prostaglandin analogues.
Hagenfeldt K; Bygdeman M
Reproduccion; 1981; 5(3):195-201. PubMed ID: 7026317
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
Shapiro AG; Lasseter K; Cobiella A; Domenzain M
Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
[TBL] [Abstract][Full Text] [Related]
17. Cervical dilatation in the nonpregnant patient with vaginal 16-dimethyl prostaglandin E2.
Nuss RC; Baird T; Benrubi G; Thompson RJ
J Fla Med Assoc; 1985 Jun; 72(6):426-7. PubMed ID: 4045400
[No Abstract] [Full Text] [Related]
18. Cervical dilatation in late first trimester termination by prostaglandin, hylase and isogel.
Mandlekar AV; Ganguli AC; Krishna UR; Purandare VN
Prostaglandins Med; 1981 Apr; 6(4):381-7. PubMed ID: 7025067
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
[TBL] [Abstract][Full Text] [Related]
20. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
Ballard CA
Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
